Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Carcinoma, Transitional Cell × Vitamins × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Polycystic Ovary Syndrome 3 Pain, Postoperative 2 Breast Neoplasms 2 Vomiting 1 Vitamin D Deficiency 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Nausea 1 Motor Activity 1 Malnutrition 1 Gastritis, Atrophic 1 Disease 1 Carcinoma, Transitional Cell 1 Breast Neoplasms, Male 1

Interventions

pembrolizumab 76 Gemcitabine 47 Nivolumab 40 Cisplatin 34 atezolizumab 29 Carboplatin 27 avelumab 22 Docetaxel 22 enfortumab vedotin 21 Magnetic Resonance Spectroscopy 16 Paclitaxel 15 Ipilimumab 15 Specimen Handling 12 Mitomycin 12 durvalumab 10 toripalimab 9 sacituzumab govitecan 9 Pemetrexed 8 vinflunine 7 cabozantinib 7 Taxes 7 Injections 6 Cyclophosphamide 6 Bevacizumab 6 tislelizumab 5 pemigatinib 5 Standard of Care 5 Fluorodeoxyglucose F18 5 Biopsy 5 lenvatinib 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01490437 2014-09-25

PECULIAR

Asan Medical Center

Phase 2 Completed

Carcinoma, Transitional Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡